title: Maternal caffeine intake and intrauterine growth retardation.
abstract: This study estimates the effect of maternal caffeine consumption throughout pregnancy on fetal growth. We studied 2,714 women who delivered a liveborn infant between 1988 and 1991. Detailed information regarding coffee, tea, and soda drinking during the first and third trimesters of pregnancy was obtained. Average caffeine intake during month 1 of pregnancy was higher than for month 7 (72.4 vs 54.0 mg per day). Consumption of >300 mg caffeine per day during month 1 (adjusted odds ratio = 0.91; 95% confidence interval = 0.44--1.90) and during month 7 (adjusted odds ratio = 1.00; 95% confidence interval = 0.37--2.70) was not associated with intrauterine growth retardation. There was little evidence for any effect modification due to cigarette smoking on the caffeine associations. This study provides evidence that antenatal caffeine consumption has no adverse effect on fetal growth.
authors: Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520, USA.
authors: L M
authors: LM
authors: Grosso
authors: K D
authors: KD
authors: Rosenberg
authors: K
authors: K
authors: Belanger
authors: A F
authors: AF
authors: Saftlas
authors: B
authors: B
authors: Leaderer
authors: M B
authors: MB
authors: Bracken
mesh_terms: D000328:Adult; D001724:Birth Weight; D002110:Caffeine / Q000008:administration & dosage / Q000009:adverse effects*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects*; D015331:Cohort Studies; D005260:Female; D005317:Fetal Growth Retardation / Q000209:etiology*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D018811:Maternal Exposure; D011247:Pregnancy
chemical_list: D000697:Central Nervous System Stimulants; D002110:Caffeine